TFF Pharmaceuticals COO Christopher Cano's 2021 pay falls 52% to $664K
TFF Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: September 21, 2022
TFF Pharmaceuticals reported fiscal year 2021 executive compensation information on September 21, 2022.
In 2021, three executives at TFF Pharmaceuticals received on average a compensation package of $546K, a 70% decrease compared to previous year.
Average pay of disclosed executives at TFF Pharmaceuticals
Christopher Cano, Chief Operating Officer, received $664K in total, which decreased by 52% compared to 2020. 49% of Cano's compensation, or $325K, was in salary. Cano also received $62K in bonus and $277K in option awards.
Glenn Mattes, Chief Executive Officer, received a compensation package of $596K, which decreased by 82% compared to previous year. 75% of the compensation package, or $450K, was in salary.
Kirk Coleman, Chief Financial Officer, earned $379K in 2021, a 50% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on September 21, 2022.